-
-
-
-
-
-
-
Increasing unusual option volume: UNM CGNX UNCY CNXC NN DOMO JACK SOLS KSTR
-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) PT Lowered to $23 at Brookline Capital Markets
-
-
-
-
-
-
-
Unicycive resubmits drug application for kidney disease treatment
-
-
-
-
-
-
-
Unicycive expects to resubmit drug application by year-end after FDA meeting
-
-
-
-
-
-
-
Unicycive (UNCY) Will Seek Type A Meeting to Resolve CRL Issues: Benchmark
-
-
-
-
-
-
-
Benchmark Reiterates Speculative Buy Rating on Unicycive Therapeutics (UNCY)
-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) Announces Publication of Positive Oxylanthanum Carbonate (OLC) Dose Escalation Data in Clinical and Translational Science
-
459,814 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

